IE
PRAX icon

Israel Englander’s Praxis Precision Medicines PRAX Stock Holding History

Israel Englander’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,300
Closed -$2.74M – 6238
2025
Q4 		$2.74M Buy
9,300
+1,300
+16% +$242K ﹤0.01% 3660
2025
Q3 		$424K Buy
+8,000
New +$388K ﹤0.01% 5177

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Israel Englander's PRAX Position: Q2 2026 in Review

Israel Englander reduced its Praxis Precision Medicines (PRAX) stake by 74% in Q2 2026, selling an estimated $898K and leaving 995 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #5055.

Israel Englander first reported a position in PRAX in Q1 2021 and has held it in 19 quarters since. The position peaked at $11.6M in Q4 2024. 307 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Israel Englander held 995 shares of Praxis Precision Medicines worth $333K as of Q2 2026.
  • Israel Englander sold 2,836 Praxis Precision Medicines shares in Q2 2026, an estimated $898K.
  • Praxis Precision Medicines made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5055 holding.
  • Israel Englander first reported a position in Praxis Precision Medicines in Q1 2021 and has held it in 19 quarters since.
  • Israel Englander's Praxis Precision Medicines position peaked at $11.6M in Q4 2024.
  • 307 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.